genome analysis
GeneDx Q2 Revenues Grow 45 Percent Driven by Exome, Genome Tests
The company saw a 52 percent year-over-year increase in whole-exome and whole-genome testing volume during Q2, booking $50.7 million in revenues for this business segment.
GeneDx Lays off 10 Percent of Staff as Part of $40M Cost Cutting Plan, Secures $75M Debt Financing
The clinical genetic testing company also lowered its revenue guidance for 2023 and reported $53.3 million in revenues for the third quarter.
Euformatics Forms Distribution Partnership for Eastern Europe With Bulgaria's Elta 90
The bioinformatics firm will sell its Genomics Hub software to labs and research institutes in Romania, North Macedonia, and Moldova through a local partner.
Sophia Genetics to Commercialize MSK-ACCESS Clinical Liquid Biopsy Test
The collaboration between Sophia and Memorial Sloan Kettering Cancer Center aims to offer new testing and analytics capabilities to clinicians and researchers.
Variantyx Secures $20M Debt Financing to Support Precision Medicine in North America, Europe
The maker of diagnostic WGS analysis software looks to grow its market share after expanding into oncology and prenatal testing last year.